How many insider trades does FilingIQ track for FHTX?

FilingIQ tracks 66 Form 4 insider transactions for FHTX (Foghorn Therapeutics Inc.), covering filings from Oct 27, 2020 onwards. 5 of those were filed in the last 90 days.

Are FHTX insiders net buyers or net sellers?

Across the full Form 4 history for FHTX, 5 transactions (8%) were open-market purchases and 8 (12%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does FHTX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is FHTX in?

Foghorn Therapeutics Inc. (FHTX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $328.94M.

FHTX insider trading

Healthcare

Foghorn Therapeutics Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

8% / 12%

Market cap

$328.94M

About Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is also developing therapies for mutant cancers, such as androgen receptor, positive prostate cancer, bladder cancer, Non-Small Cell Lung (NSCLC), as well as various lymphomas and leukemias; melanoma, endometrial, gastric, breast, colorectal, and pancreatic cancers; and dependent cancers, including prostate cancer and diffuse large b-cell lymphoma. The company has collaboration agreement with Eli Lilly and Company for developing FHD-909, a selective ATPase inhibitor of BRM. Foghorn Therapeutics Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Company website: foghorntx.com

FHTX insider activity at a glance

FilingIQ has scored 66 insider transactions for FHTX since Oct 27, 2020. The most recent filing in our index is dated Apr 10, 2026.

Across the full history, 5 open-market purchases and 8 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on FHTX insider trades is 50.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live FHTX trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding FHTX

Euclidean Capital LLC

$7.87M · 1.7% of AUM

Frequently asked

How many insider trades does FilingIQ track for FHTX?: FilingIQ tracks 66 Form 4 insider transactions for FHTX (Foghorn Therapeutics Inc.), covering filings from Oct 27, 2020 onwards. 5 of those were filed in the last 90 days.
Are FHTX insiders net buyers or net sellers?: Across the full Form 4 history for FHTX, 5 transactions (8%) were open-market purchases and 8 (12%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does FHTX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is FHTX in?: Foghorn Therapeutics Inc. (FHTX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $328.94M.

Methodology & sources

Every FHTX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.